Tan DTM, See KC. Diagnosis and management of severe pulmonary and extrapulmonary tuberculosis in critically ill patients: A mini review for clinicians. World J Crit Care Med 2024; 13(2): 91435 [PMID: 38855275 DOI: 10.5492/wjccm.v13.i2.91435]
Corresponding Author of This Article
Dominic Ti Ming Tan, MBChB, Doctor, Department of Medicine, National University Hospital, 1E Kent Ridge Road, Singapore 119228, Singapore. dominic.tan.ti.ming@gmail.com
Research Domain of This Article
Critical Care Medicine
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Table 4 Dose adjustment in antituberculosis therapies in patients with renal dysfunction
Antimycobacterial agent
Normal daily dose in adults
CrCl 30-60
CrCl 10-29
CrCl < 10
Haemodialysis
Peritoneal dialysis
Isoniazid
5 mg/kg (typically 300 mg)
No dose adjustment
No dose adjustment
No dose adjustment
No dose adjustment
No dose adjustment
Rifampicin
10 mg/kg (typically 600 mg)
No dose adjustment
No dose adjustment
No dose adjustment
No dose adjustment
No dose adjustment
Ethambutol
15 mg/kg
15 mg/kg/d
15 mg/kg q48h
15 mg/kg q48h
15 mg/kg three times weekly post-HD
15 mg/kg q48h
Pyrazinamide
15-30mg/kg
No dose adjustment
15-30 mg/kg q48h
15-30 mg/kg three times weekly
15-30 mg/kg three times weekly post-HD
No dose adjustment
Citation: Tan DTM, See KC. Diagnosis and management of severe pulmonary and extrapulmonary tuberculosis in critically ill patients: A mini review for clinicians. World J Crit Care Med 2024; 13(2): 91435